Overview

Blood Bags Market Overview:

Blood and its components, including platelets, plasma, and cryoprecipitate, are transferred, collected, stored, and transfused using a blood bag. It's usually made of biocompatible PVC and comes with collection tubes, needles, needle coverings, and clamps built in. Citrate Phosphate Dextrose Adenine (CPDA) blood bags, Saline Adenine Glucose Mannitol (SAGM) blood bags, and transfer bags are the most common types of blood bags on the market. They are divided into single, double, triple, and quadruple blood collection bags based on the sorts of transfusions they are used for. Surgical centres, trauma centres, emergency rooms, ambulatory care facilities, and critical care units all use these bags. Furthermore, the rising frequency of various blood-related medical conditions, such as anaemia, haemophilia, myeloma, and leukaemia, is pushing blood transfusion demand. The expansion of the blood bag market is being fueled by numerous invasive surgical operations in the sectors of cardiology, neurology, orthopaedics, oncology, and others. Blood banks, medical research laboratories, and diagnostic facilities are also being established as a result of increased investments in healthcare infrastructure development. The market for blood bags is also being boosted by the development of multiple blood donation programmes by various government entities and non-profit groups. The rising frequencies of fatal accidents, as well as the widespread presence of trauma centres around the world, are driving the worldwide blood bags market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Blood Bags Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Blood Bags Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Blood Bags Market:
• Advacare Pharma
• BL Life Sciences Private Limited
• Demophorius Healthcare Ltd.
• Fresenius SE & Co. KGaA.
• Grifols S.A.
• Haemonetics Corporation
• HLL Lifecare Limited
• Innvol
• JMS Co. Ltd.
• Kawasumi Laboratories, Inc.
• Maco Pharma International GmbH
• Mitra Industries Pvt. Ltd.
• Neomedic Limited
• Poly Medicure Ltd.
• Span Healthcare Private Limited
• Suru International Private Ltd.
• Teleflex Incorporated
• Terumo Corporation
• The Metrix Company Ltd.
• Troge Medical GmbH.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Blood Bags Market Segmentation:
By Product Type
• Single Blood Bag
• Double Blood Bag
• Triple Blood Bag
• Quadruple Blood Bag
• Penta Blood Bag
By Application
• Collection Blood Bag
• Transfer Blood Bag
By Material
• Poly Vinyl Chloride Blood Bag
• Polyethylene Terephthalate Blood Bag
• Others
By End User
• Hospitals
• Clinics
• Ambulatory Surgical Centre
• Blood Banks
• Others
By Capacity
• 100 ml Blood Bag
• 150 ml Blood Bag
• 250 ml Blood Bag
• 300 ml Blood Bag
• 350 ml Blood Bag
• 400 ml Blood Bag
• 450 ml Blood Bag
• 500 ml Blood Bag
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Blood Bags Market By Product Type, By Application, By Material, By End User, By Capacity and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1. Objectives of the Study
  1.2. Market Definition
  1.3. Market Scope
       1.3.1. Years Considered for the Study
       1.3.2. Market Covered
  1.4. Currency
  1.5. Limitations
  1.6. Stakeholders

2. Research Methodology
  2.1. Research Data
       2.1.1. Secondary Data
              2.1.1.1. Key Data from Secondary Sources
       2.1.2. Primary Data
              2.1.2.1. Key Data from Primary Sources
  2.2. Market Size Estimation
  2.3. Market Breakdown and Data Triangulation
  2.4. Assumptions for the Study  

3. Executive Summary
  3.1. Market Outlook
  3.2. Segment Outlook
  3.3. Competitive Insights

4. Blood Bags Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Blood Bags Market Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Blood Bags Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Blood Bags Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. Single Blood Bag
  7.2. Double Blood Bag
  7.3. Triple Blood Bag
  7.4. Quadruple Blood Bag
  7.5. Penta Blood Bag

8. Blood Bags Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)  
  8.1. Collection Blood Bag
  8.2. Transfer Blood Bag

9. Blood Bags Market, By Material Historical Analysis and Forecast 2022-2028 (USD Million)  
  9.1. Poly Vinyl Chloride Blood Bag
  9.2. Polyethylene Terephthalate Blood Bag
  9.3. Others

10. Blood Bags Market, By End Users Historical Analysis and Forecast 2022-2028 (USD Million)  
   10.1. Hospitals
   10.2. Clinics
   10.3. Ambulatory Surgical Centre
   10.4. Blood Banks
   10.5. Others

11. Blood Bags Market, By Capacity Historical Analysis and Forecast 2022-2028 (USD Million)  
   11.1. 100 ml Blood Bag
   11.2. 150 ml Blood Bag
   11.3. 250 ml Blood Bag
   11.4. 300 ml Blood Bag
   11.5. 350 ml Blood Bag
   11.6. 400 ml Blood Bag
   11.7. 450 ml Blood Bag
   11.8. 500 ml Blood Bag

12. North America Blood Bags Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   12.1. Introduction
   12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         12.2.1. U.S.A
         12.2.2. Canada
         12.2.3. Mexico
   12.3. Market Size (USD Million) Forecast for North America 2022-2028

13. Latin America Blood Bags Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         13.2.1. Brazil
         13.2.2. Venezuela
         13.2.3. Argentina
         13.2.4. Rest of Latin America
   13.3. Market Size (USD Million) Forecast for Latin America 2022-2028

14. Europe Blood Bags Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         14.2.1. Germany
         14.2.2. U.K        
         14.2.3. France
         14.2.4. Italy
         14.2.5. Spain
         14.2.6. Russia
         14.2.7. Poland
         14.2.8. Rest of Europe
   14.3. Market Size (USD Million) Forecast for Europe 2022-2028

15. Asia Pacific Blood Bags Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   15.1. Introduction
   15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         15.2.1. Japan
         15.2.2. China
         15.2.3. India
         15.2.4. Australia and New Zealand
         15.2.5. ASEAN
         15.2.6. Rest of Asia Pacific
   15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   16.1. Introduction
   16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         16.2.1. GCC
         16.2.2. Israel
         16.2.3. South Africa
         16.2.4. Rest of MEA
   16.3. Market Size (USD Million) Forecast for MEA 2022-2028

17. Market Share Analysis and Competitive Landscape  
   17.1. Global Landscape - Key Players, Revenue and Presence
   17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   17.3. Global Emerging Companies
   17.4. North America - Market Share Analysis and Key Regional Players
   17.5. Europe - Market Share Analysis and Key Regional Players
   17.6. Asia Pacific - Market Share Analysis and Key Regional Players
   17.7. Global Key Player - Growth Matrix

18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   18.1. Advacare Pharma
         18.1.1. Company Overview
         18.1.2. Product Portfolio
         18.1.3. SWOT Analysis
         18.1.4. Financial Overview
         18.1.5. Strategic Overview
   18.2. BL Life Sciences Private Limited
         18.2.1. Company Overview
         18.2.2. Product Portfolio
         18.2.3. SWOT Analysis
         18.2.4. Financial Overview
         18.2.5. Strategic Overview
   18.3. Demophorius Healthcare Ltd.
         18.3.1. Company Overview
         18.3.2. Product Portfolio
         18.3.3. SWOT Analysis
         18.3.4. Financial Overview
         18.3.5. Strategic Overview
   18.4. Fresenius SE & Co. KGaA.
         18.4.1. Company Overview
         18.4.2. Product Portfolio
         18.4.3. SWOT Analysis
         18.4.4. Financial Overview
         18.4.5. Strategic Overview
   18.5. Grifols S.A.
         18.5.1. Company Overview
         18.5.2. Product Portfolio
         18.5.3. SWOT Analysis
         18.5.4. Financial Overview
         18.5.5. Strategic Overview          
   18.6. Haemonetics Corporation
         18.6.1. Company Overview
         18.6.2. Product Portfolio
         18.6.3. SWOT Analysis
         18.6.4. Financial Overview
         18.6.5. Strategic Overview
   18.7. HLL Lifecare Limited
         18.7.1. Company Overview
         18.7.2. Product Portfolio
         18.7.3. SWOT Analysis
         18.7.4. Financial Overview
         18.7.5. Strategic Overview
   18.8. Innvol
         18.8.1. Company Overview
         18.8.2. Product Portfolio
         18.8.3. SWOT Analysis
         18.8.4. Financial Overview
         18.8.5. Strategic Overview
   18.9. JMS Co. Ltd.
         18.9.1. Company Overview
         18.9.2. Product Portfolio
         18.9.3. SWOT Analysis
         18.9.4. Financial Overview
         18.9.5. Strategic Overview          
   18.10.Kawasumi Laboratories, Inc.
         18.10.1. Company Overview
         18.10.2. Product Portfolio
         18.10.3. SWOT Analysis
         18.10.4. Financial Overview
         18.10.5. Strategic Overview
   18.11.Maco Pharma International GmbH
         18.11.1. Company Overview
         18.11.2. Product Portfolio
         18.11.3. SWOT Analysis
         18.11.4. Financial Overview
         18.11.5. Strategic Overview          
   18.12.Mitra Industries Pvt. Ltd.
         18.12.1. Company Overview
         18.12.2. Product Portfolio
         18.12.3. SWOT Analysis
         18.12.4. Financial Overview
         18.12.5. Strategic Overview
   18.13.Neomedic Limited
         18.13.1. Company Overview
         18.13.2. Product Portfolio
         18.13.3. SWOT Analysis
         18.13.4. Financial Overview
         18.13.5. Strategic Overview
   18.14.Poly Medicure Ltd.
         18.14.1. Company Overview
         18.14.2. Product Portfolio
         18.14.3. SWOT Analysis
         18.14.4. Financial Overview
         18.14.5. Strategic Overview
   18.15.Span Healthcare Private Limited
         18.15.1. Company Overview
         18.15.2. Product Portfolio
         18.15.3. SWOT Analysis
         18.15.4. Financial Overview
         18.15.5. Strategic Overview
   18.16.Suru International Private Ltd.
         18.16.1. Company Overview
         18.16.2. Product Portfolio
         18.16.3. SWOT Analysis
         18.16.4. Financial Overview
         18.16.5. Strategic Overview
   18.17.Teleflex Incorporated
         18.17.1. Company Overview
         18.17.2. Product Portfolio
         18.17.3. SWOT Analysis
         18.17.4. Financial Overview
         18.17.5. Strategic Overview
   18.18.Terumo Corporation
         18.18.1. Company Overview
         18.18.2. Product Portfolio
         18.18.3. SWOT Analysis
         18.18.4. Financial Overview
         18.18.5. Strategic Overview
   18.19.The Metrix Company Ltd.
         18.19.1. Company Overview
         18.19.2. Product Portfolio
         18.19.3. SWOT Analysis
         18.19.4. Financial Overview
         18.19.5. Strategic Overview
   18.20. Medical GmbH.
         18.20.1. Company Overview
         18.20.2. Product Portfolio
         18.20.3. SWOT Analysis
         18.20.4. Financial Overview
         18.20.5. Strategic Overview

19. Pre and Post COVID-19 Impact
   19.1. Positive influence on the healthcare industry
   19.2. The financial disruption of the manufacturing sector
   19.3. Impact of COVID-19 on emerging companies
   19.4. Significant mandates in the healthcare regulations initiated by administrations
   19.5. The overall economic slowdown of the developing and developed nations

20. FutureWise SME Key Takeaway Points for Client

Tables

Figures